Jane Street’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Jane Street's ARKG Position: Q1 2026 in Review
Jane Street reduced its ARK Genomic Revolution ETF (ARKG) stake by 83% in Q1 2026, selling an estimated $14.2M and leaving 96,335 shares worth $2.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4647.
Jane Street first reported a position in ARKG in Q4 2014 and has held it in 41 quarters since. The position peaked at $71.8M in Q4 2020. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Jane Street held 96,335 shares of ARK Genomic Revolution ETF worth $2.55M as of Q1 2026.
- Jane Street sold 484,079 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $14.2M.
- ARK Genomic Revolution ETF made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4647 holding.
- Jane Street first reported a position in ARK Genomic Revolution ETF in Q4 2014 and has held it in 41 quarters since.
- Jane Street's ARK Genomic Revolution ETF position peaked at $71.8M in Q4 2020.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.